Considerations on photochemical genotoxicity. II: Report of the 2009 International Workshop on Genotoxicity Testing Working Group

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 723, Issue 2, 2011, Pages 91-100

  Lynch, Anthony M ^a   Guzzie, Peggy J ^b   Bauer, Daniel ^c   Gocke, Elmar ^d   Itoh, Satoru ^e   Jacobs, Abby ^f   Krul, Cyrille A M ^g   Schepky, Andreas ^h   Tanaka, Noriho ⁱ   Kasper, Peter ^j  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Johnson and Johnson   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e DAIICHI SANKYO CO   (Japan)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g TNO   (Netherlands)

^h BEIERSDORF AG   (Germany)

ⁱ HATANO RESEARCH INSTITUTE   (Japan)

^j Federal Institute for Drugs and Medical Devices   (Germany)

more..

Author keywords

Photoclastogenicity; Photogenotoxicity; Photosafety; Phototoxicity; Risk assessment

Indexed keywords

ARTICLE; EUROPE; GENOTOXICITY; IN VITRO STUDY; OCCUPATIONAL SAFETY; PATIENT SAFETY; PHOTOCHEMISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICITY TESTING; UNITED STATES;

ANIMALS; COMET ASSAY; DRUG AND NARCOTIC CONTROL; EYE; GUIDELINES AS TOPIC; MICRONUCLEUS TESTS; MODELS, ANIMAL; MUTAGENICITY TESTS; PHOTOCHEMICAL PROCESSES; RATS; RISK ASSESSMENT; SKIN; TOXICITY TESTS;

LONCHOCARPUS GLAUCIFOLIUS;

EID: 79959742565     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.10.010     Document Type: Article

References (43)

1. Epstein J.H. Phototoxicity and photoallergy in man. J. Am. Acad. Dermatol. 1983, 8:141-147.
2. Parisi A.V., Wong J.C.F. Erythemal irradiances of filtered ultraviolet radiation. Phys. Med. Biol. 1997, 42:1263-1275.
3. Johnson B.E., Ferguson J. Drug and chemical photosensitivity. Semin. Dermatol. 1990, 9:39-46.
4. Moore D.E. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002, 25:345-372.
5. FDA/CDER Guidance for Industry: Photosafety Testing, 2003.
6. SCCNFP/0690/03: Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 5th revision, 2003.
7. EMA, CPMP/SWP/398/01 "Note for Guidance on Photosafety Testing", London, 2002, (accessed 30.07.2010). http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp%3FwebContentId=WC500003353.
8. Gocke E., Muller L., Guzzie P.J., Brendler-Schwaab S., Bulera S., Chignell C.F., Henderson L.M., Jacobs A., Murli H., Snyder R.D., Tanaka N. Considerations on photochemical genotoxicity: report of the International Workshop on Genotoxicity Test Procedures Working. Environ. Mol. Mutagen. 2000, 35:173-184.
9. ICH, ICH M3 (R2) Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals, 2009, (accessed 30.07.2010). http://www.ich.org/cache/compo/276-254-1.html.
10. Spielmann H., Balls M., Dupuis J., Pape W.J., Pechovitch G., De Silva O., Holzhutter H.G., Clothier R., Desolle P., Gerberick F., Liebsch M., Lovell W.W., Maurer T., Pfannenbecker U., Potthast J.M., Csato M., Sladowski D., Steiling W., Brantom P. The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial). Part 1. The 3T3 NRU phototoxicity test. Toxicol. Vitro 1998, 12:305-327.
11. Spielmann H., Muller L., Averbeck D., Balls M., Brendler-Schwaab S., Castell J.V., Curren R., De Silva O., Gibbs N.K., Liebsch M., Lovell W.W., Merk H.F., Nash J.F., Neumann N.J., Pape W.J.W., Ulrich P., Vohr H.W. The second ECVAM workshop on phototoxicity testing: the report and recommendations of ECVAM workshop. ATLA 2000, 28:777-814.
12. OECD OECD Guidelines for the Testing of Chemicals: Test Guideline 432 "In vitro 3T3 NRU Phototoxicity Test' 2004, OECD Publication Office, France, Paris.
13. Lynch A.M., Wilcox P. Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry. Exp. Toxicol. Path. 2010, 10.1016/j.etp.2009.12.001.
14. JPMA (Japan Pharmaceutical Manufacturers Association). Material 148. Investigation of the regulations for photosafety evaluation of pharmaceutical drugs in Japan, the U.S. and Europe, and report of investigation for accumulation of basic data to be used for development of photosafety evaluation procedures, unpublished results, 2010.
15. Lynch A.M., Robinson S.A., Wilcox P., Smith M.D., Kleinman M., Jiang K., Rees R.W. Cycloheximide and disulfoton are positive in the photoclastogencity assay but do not absorb UV irradiation: another example of pseudophotoclastogenicity?. Mutagenesis 2008, 23:111-118.
16. Henry B., Foti C., Alsante K. Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule?. J. Photochem. Photobiol. B Biol. 2009, 96:57-62.
17. OECD OECD Guidelines for the Testing of Chemicals: Test Guideline 101 "UV-Vis Absorption" 1981, OECD Publication Office, France, Paris.
18. Kleinman M.H., Smith M.D., Kurali E., Reeser S., Jiang K., Zhang Y., Kennedy-Gabb S.A., Lynch A.M., Geddes C.D. An evaluation of chemical photoreactivity and the relationship to phototoxicity. Regul. Toxicol. Pharmacol. 2010, 10.1016/j.yrtph.2010.06.013.
19. Lynch A.M., Smith M.D., Lane A.S., Robinson S.A., Kleinman M.H., Kennedy-Gabb S., Wilcox P., Rees R.W. An evaluation of chemical photoreactivity and the relationship to photogenotoxicity. Regul. Toxicol. Pharmacol. 2009, 10.1016/j.yrtph.2009.11.003.
20. Pape W.J.W., Maurer T., Pfannenbecker U., Steiling W. The red blood cell phototoxicity test (photohaemolysis and haemoglobin oxidation): EU/COLIPA Validation Programme on Phototoxicity (Phase II). ATLA 2001, 29:145-162.
21. Liebsch M., Spielmann H., Pape W.J.W., Krul C., Deguercy A., Eskes C. UV-induced effects. ATLA 2005, 33:131-146.
22. Dufour E.K., Tirukalikundram K., Gerhard J., Nohynek G.J., Kirkland D., Toutain H. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutat. Res. 2006, 607:215-224.
23. Gocke E., Chételat A.A. Photochemical genotoxicity testing: experience with the Ames test and the in vitro chromosomal aberration assay. Environ. Mutagen. Res. 2001, 23:47-51.
24. Chételat A.A., Albertini S., Gocke E. The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay). Mutagenesis 1996, 11:497-504.
25. Brendler-Schwaab S., Czich A., Epe B., Gocke E., Kaina B., Müller L., Pollet D., Utesch D. Photochemical genotoxicity: principles and test methods - report of a GUM task force. Mutat. Res. 2004, 566:65-91.
26. Gocke E. Review of the genotoxic properties of chlorpromazine and related phenothiazines. Mutat. Res. 1996, 366:9-21.
27. Bulera S.J., Theiss C., Festerling A., de la Iglesia F.A. In vitro photogenotoxic activity of clinafoxac a paradigm predicting photocarcinogenicity. Toxicol. Appl. Pharm. 1999, 156:222-230.
28. Wirnitzer U., Gross-Tholl N., Herbold B., von Keutz E. Photo-chemically induced DNA effects in the comet assay with epidermal cells of SKH-1 mice after a single oral administration of different fluoroquinolones and 8-methoxypsoralen in combination with exposure to UVA. Mutat. Res. 2006, 609:1-10.
29. Struwe M., Greulich K.O., Junker U., Jean C., Zimmer D., Suter W., Plappert-Helbig U. Detection of photogenotoxicity in skin and eye in rat with the photo comet assay. Photochem. Photobiol. Sci. 2008, 7:240-249.
30. Itoh S., Katoh M., Furuhama K. In vivo photochemical micronucleus induction due to certain quinolone antimicrobial agents in the skin of hairless mice. Mutat. Res. 2002, 520:133-139.
31. Hara T., Nishikawa T., Sui H., Kawakami K., Matsumoto H., Tanaka N. In vivo photochemical skin micronucleus test using a sunlight simulator: detection of 8-methoxypsoralen and benzo[a]pyrene in hairless mice. Mutat. Res. 2007, 631:1-8.
32. Reus A.A., Usta M., van Meeuwen R.N., Maas W.J., Robinson S.A., Kenny J.D., Pruimboom-Brees I., Clements P.J., Lynch A.M., Krul C.A. Development and characterization of an in vivo skin photomicronucleus assay in rats. Mutagenesis 2010, 25:407-416.
33. Struwe M., Greulich K.O., Perentes E., Martus H.-J., Zimmer D., Suter W., Plappert-Helbig U. Repair of sparfloxacin-induced photochemical DNA damage in vivo. J. Invest. Dermatol. 2009, 129:699-704.
34. Potts R.O., Bommannan B., Guy R.H. Percutaneous absorption. Pharmacology of the Skin 1992, 12-27. CRC Press, USA. H. Mukhtar (Ed.).
35. Oesch F., Fabian E., Oesch-Bartlomowicz B., Werner C., Landsiedel R. Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab. Rev. 2007, 39:659-698.
36. Liebsch M., Traue D., Barrabas C., Spielmann H., Gerberick G.F., Cruse L., Diembeck W., Pfannenbecker U., Spieker J., Holzhütter H.-G., Brantom P., Aspin P., Southee J. Prevalidation of the EpiDermTM phototoxicity test. Alternatives to Animal Testing II 1999, 160-167. COLIPA, Brussels. D.G. Clark, S.G. Lisansky, R. Macmillan (Eds.).
37. Lelièvre D., Justine P., Christiaens F., Bonaventure N., Coutet J., Marrot L., Cotovio J. The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol. Vitro 2007, 21:977-995.
38. Curren R.D., Mun G.C., Gibson D.P., Aardema M.J. Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). Mutat. Res. 2006, 607:192-204.
39. Hu T., Kaluzhny Y., Mun G.C., Barnett B., Karetsky V., Wilt N., Klausner M., Curren R.D., Aardema M.J. Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res. 2009, 673:100-108.
40. Flamand N., Marrot L., Belaidi J.P., Bourouf L., Dourille E., Feltes M., Meunier J.R. Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds. Mutat. Res. 2006, 606:39-51.
41. Pfuhler S., Kirst A., Aardema M., Banduhn N., Goebel C., Araki D., Costabel-Farkas M., Dufour E., Fautz R., Harvey J., Hewitt N.J., Hibatallah J., Carmichael P., Macfarlane M., Reisinger K., Rowland J., Schellauf F., Schepky A., Scheel J. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: Genotoxicity. A COLIPA analysis. Regul. Toxicol. Pharmacol. 2010, 57:315-324.
42. EMA, EMEA/CHMP/SWP/534549/2007 "Concept Paper on the Need for Revision of the Note for Guidance on Photosafety Testing", London, 2008, (accessed 30.07.2010). http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp%3FwebContentId=WC500003358.
43. SCCP/1005/06, Notes of Guidance for Testing of Cosmetic Ingredients and Their Safety Evaluation, 6th revision, 2006, (accessed 30.07.2010). http://ec.europa.eu/health/archive/ph_risk/committees/04_sccp/docs/sccp_s_04.pdf.